Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Fri 2 Apr 2004, 15:36 Scheme of arrangement proposed by Business Ventur
African Oxygen Limited - Scheme of arrangement proposed by Business Venture     
  Investments No 790 (Proprietary) Limited between Afrox Healthcare Limited and   
  its shareholders                                                                
  African Oxygen Limited                                                          
  (Incorporated in the Republic of South Africa)                                  
  (Registration number 1927/000089/06)                                            
  Share code: AFX                                                                 
  ISIN: ZAE000030920                                                              
  ("Afrox")                                                                       
  Scheme of arrangement proposed by Business Venture Investments No 790           
  (Proprietary) Limited between Afrox Healthcare Limited and its shareholders     
  The attention of Afrox shareholders is drawn to the joint announcement published
  today by Business Venture Investments No 790 (Proprietary) Limited ("Bidco") and
  Afrox Healthcare Limited ("Ahealth") regarding the scheme of arrangement        
  proposed by Bidco between Ahealth and its shareholders. In terms of the         
  announcement Ahealth shareholders, of which Afrox is one, were advised that the 
  implementation of the scheme is still subject to the fulfilment of certain      
  conditions precedent, including:                                                
       -    the sanction of the scheme by the High Court of South Africa;         
  -    the registration of a certified copy of the Order of Court sanctioning
  the scheme by the Registrar of Companies in terms of the Companies Act; and     
       -    the obtaining of the requisite approvals for the implementation of    
  Bidco"s acquisition of Ahealth from the Competition Authorities in terms of the 
  Competition Act, 89 of 1998.                                                    
  As the approval of the Competition Authorities is still awaited, the last day   
  for Ahealth shareholders to trade on the JSE Securities Exchange South Africa to
  be eligible to receive the consideration payable in terms of the scheme, has    
  been postponed. It is expected that a further announcement incorporating the    
  revised salient dates and the status of the remaining conditions precedent will 
  be made in due course.                                                          
  Johannesburg                                                                    
  2 April 2004                                                                    
  Financial advisor to Afrox                                                      
  JPMorgan                                                                        
  Legal advisor to Afrox                                                          
  Bowman-Gilfillan                                                                
  Competition Law advisors to Afrox                                               
  Edward Nathan & Friedland                                                       
  Sponsor to Afrox                                                                
  Nedbank Capital                                                                 
  Date: 02/04/2004 03:05:40 PM Produced by the JSE SENS Department                
                                                                                  
                                                                                  
                                                                                  
  



 
 
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: